312 related articles for article (PubMed ID: 33821664)
1. All Roads Lead to Rome (the Heart): Cell Retention and Outcomes From Various Delivery Routes of Cell Therapy Products to the Heart.
Li J; Hu S; Zhu D; Huang K; Mei X; López de Juan Abad B; Cheng K
J Am Heart Assoc; 2021 Apr; 10(8):e020402. PubMed ID: 33821664
[TBL] [Abstract][Full Text] [Related]
2. Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold.
Nakamuta JS; Danoviz ME; Marques FL; dos Santos L; Becker C; Gonçalves GA; Vassallo PF; Schettert IT; Tucci PJ; Krieger JE
PLoS One; 2009 Jun; 4(6):e6005. PubMed ID: 19547700
[TBL] [Abstract][Full Text] [Related]
3. Cell delivery routes for stem cell therapy to the heart: current and future approaches.
Campbell NG; Suzuki K
J Cardiovasc Transl Res; 2012 Oct; 5(5):713-26. PubMed ID: 22648235
[TBL] [Abstract][Full Text] [Related]
4. Retrograde Coronary Venous Infusion as a Delivery Strategy in Regenerative Cardiac Therapy: an Overview of Preclinical and Clinical Data.
Gathier WA; van Ginkel DJ; van der Naald M; van Slochteren FJ; Doevendans PA; Chamuleau SAJ
J Cardiovasc Transl Res; 2018 Jun; 11(3):173-181. PubMed ID: 29392536
[TBL] [Abstract][Full Text] [Related]
5. Choice of cell-delivery route for successful cell transplantation therapy for the heart.
Fukushima S; Sawa Y; Suzuki K
Future Cardiol; 2013 Mar; 9(2):215-27. PubMed ID: 23463974
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury.
Collantes M; Pelacho B; García-Velloso MJ; Gavira JJ; Abizanda G; Palacios I; Rodriguez-Borlado L; Álvarez V; Prieto E; Ecay M; Larequi E; Peñuelas I; Prósper F
J Transl Med; 2017 Mar; 15(1):56. PubMed ID: 28288654
[TBL] [Abstract][Full Text] [Related]
7. Chemical Engineering of Cell Therapy for Heart Diseases.
Li Z; Hu S; Cheng K
Acc Chem Res; 2019 Jun; 52(6):1687-1696. PubMed ID: 31125198
[TBL] [Abstract][Full Text] [Related]
8. Cellular cardiomyoplasty: routes of cell delivery and retention.
Al Kindi A; Ge Y; Shum-Tim D; Chiu RC
Front Biosci; 2008 Jan; 13():2421-34. PubMed ID: 17981723
[TBL] [Abstract][Full Text] [Related]
9. Systemic and local delivery of mesenchymal stem cells for heart renovation: Challenges and innovations.
Liu Z; Mikrani R; Zubair HM; Taleb A; Naveed M; Baig MMFA; Zhang Q; Li C; Habib M; Cui X; Sembatya KR; Lei H; Zhou X
Eur J Pharmacol; 2020 Jun; 876():173049. PubMed ID: 32142771
[TBL] [Abstract][Full Text] [Related]
10. Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model.
Fukushima S; Varela-Carver A; Coppen SR; Yamahara K; Felkin LE; Lee J; Barton PJ; Terracciano CM; Yacoub MH; Suzuki K
Circulation; 2007 May; 115(17):2254-61. PubMed ID: 17438152
[TBL] [Abstract][Full Text] [Related]
11. Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery.
Li SH; Lai TY; Sun Z; Han M; Moriyama E; Wilson B; Fazel S; Weisel RD; Yau T; Wu JC; Li RK
J Thorac Cardiovasc Surg; 2009 May; 137(5):1225-33.e1. PubMed ID: 19379996
[TBL] [Abstract][Full Text] [Related]
12. Key Success Factors for Regenerative Medicine in Acquired Heart Diseases.
Hénon P
Stem Cell Rev Rep; 2020 Jun; 16(3):441-458. PubMed ID: 32297205
[TBL] [Abstract][Full Text] [Related]
13. Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences.
Pavo N; Charwat S; Nyolczas N; Jakab A; Murlasits Z; Bergler-Klein J; Nikfardjam M; Benedek I; Benedek T; Pavo IJ; Gersh BJ; Huber K; Maurer G; Gyöngyösi M
J Mol Cell Cardiol; 2014 Oct; 75():12-24. PubMed ID: 24998410
[TBL] [Abstract][Full Text] [Related]
14. Comparison of arrhythmogenicity and proinflammatory activity induced by intramyocardial or epicardial myoblast sheet delivery in a rat model of ischemic heart failure.
Pätilä T; Miyagawa S; Imanishi Y; Fukushima S; Siltanen A; Mervaala E; Kankuri E; Harjula A; Sawa Y
PLoS One; 2015; 10(4):e0123963. PubMed ID: 25860790
[TBL] [Abstract][Full Text] [Related]
15. Cell Size Critically Determines Initial Retention of Bone Marrow Mononuclear Cells in the Heart after Intracoronary Injection: Evidence from a Rat Model.
Campbell NG; Kaneko M; Shintani Y; Narita T; Sawhney V; Coppen SR; Yashiro K; Mathur A; Suzuki K
PLoS One; 2016; 11(7):e0158232. PubMed ID: 27380410
[TBL] [Abstract][Full Text] [Related]
16. On the Road to Regeneration: "Tools" and "Routes" Towards Efficient Cardiac Cell Therapy for Ischemic Cardiomyopathy.
Pagano F; Picchio V; Chimenti I; Sordano A; De Falco E; Peruzzi M; Miraldi F; Cavarretta E; Zoccai GB; Sciarretta S; Frati G; Marullo AGM
Curr Cardiol Rep; 2019 Oct; 21(11):133. PubMed ID: 31673821
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models.
Li Q; Guo Y; Ou Q; Chen N; Wu WJ; Yuan F; O'Brien E; Wang T; Luo L; Hunt GN; Zhu X; Bolli R
Basic Res Cardiol; 2011 Sep; 106(5):849-64. PubMed ID: 21516491
[TBL] [Abstract][Full Text] [Related]
18. Methods of stem cell delivery in cardiac diseases.
Perin EC; López J
Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S110-3. PubMed ID: 16501616
[TBL] [Abstract][Full Text] [Related]
19. Cell-based therapy for heart disease: a clinically oriented perspective.
Menasche P
Mol Ther; 2009 May; 17(5):758-66. PubMed ID: 19277020
[TBL] [Abstract][Full Text] [Related]
20. Intracoronary and retrograde coronary venous myocardial delivery of adipose-derived stem cells in swine infarction lead to transient myocardial trapping with predominant pulmonary redistribution.
Hong SJ; Hou D; Brinton TJ; Johnstone B; Feng D; Rogers P; Fearon WF; Yock P; March KL
Catheter Cardiovasc Interv; 2014 Jan; 83(1):E17-25. PubMed ID: 22972685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
